Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis

M Joice, GI Vasileiadis… - The bone & joint …, 2018 - boneandjoint.org.uk
Aims The aim of this study was to assess the efficacy of non-selective and selective non-
steroidal anti-inflammatory drugs (NSAIDs) in preventing heterotopic ossification (HO) after …

Prophylaxis of heterotopic ossification–an updated review

EO Baird, QK Kang - Journal of orthopaedic surgery and research, 2009 - Springer
Heterotopic ossification (HO) is defined as the process by which trabecular bone forms
outside of the skeletal structure, occupying space in soft tissue where it does not normally …

Current concepts in the development of heterotopic ossification

HC Pape, S Marsh, JR Morley, C Krettek… - The Journal of Bone …, 2004 - boneandjoint.org.uk
Heterotopic ossification can be defined as the formation of bone in tissues which normally
exhibit no properties of ossification. It is characterised by the rapid development of calcified …

[PDF][PDF] Do steroids, conventional non-steroidal anti-inflammatory drugs and selective Cox-2 inhibitors adversely affect fracture healing

LA Boursinos, T Karachalios, L Poultsides… - J Musculoskelet …, 2009 - ismni.org
Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs
worldwide. They are prescribed for orthopaedic conditions such as osteoarthritis, soft-tissue …

NSAIDs for prophylaxis for heterotopic ossification after total hip arthroplasty: a Bayesian network meta-analysis

F Migliorini, A Trivellas, J Eschweiler… - Calcified Tissue …, 2021 - Springer
Non-steroidal anti-inflammatory drugs (NSAID) have been recommended to prevent of
heterotopic ossification (HO) after total hip arthroplasty (THA), but debates are still ongoing …

Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty: a systematic review and meta-analysis

SL Kan, B Yang, GZ Ning, LX Chen, YL Li, SJ Gao… - Medicine, 2015 - journals.lww.com
Heterotopic ossification (HO) is a frequent complication after total hip arthroplasty (THA).
Nonsteroidal anti-inflammatory drugs (NSAIDs) have been used as routine prophylaxis for …

Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety

BJ Gates, TT Nguyen, SM Setter… - Expert opinion on …, 2005 - Taylor & Francis
The discovery of two distinct isoenzymes of COX has led to the development and clinical
introduction of COX-2 inhibitors with increased selectivity onto the market. Meloxicam is a …

Selective COX-2 inhibitor versus non-selective COX-2 inhibitor for the prevention of heterotopic ossification after total hip arthroplasty: A meta-analysis

XT Zhu, L Chen, JH Lin - Medicine, 2018 - journals.lww.com
Background: Whether selective non-steroidal anti-inflammatory drugs (NSAIDs) has equally
efficacy with non-selective NSAIDs in preventing heterotopic ossification (HO) after total hip …

[PDF][PDF] Celecoxib, NSAIDs and the skeleton

JP O'Connor, T Lysz - Drugs of today, 2008 - researchgate.net
Treating acute and chronic musculoskeletal pain is essential for improving healing of
traumatic injuries and surgical procedures, and for improving patient quality of life …

Pharmacological interventions for treating acute heterotopic ossification

MJ Haran, T Bhuta, BSB Lee - Cochrane Database of …, 2004 - cochranelibrary.com
Background Heterotopic ossification (HO) is the formation of mature lamellar bone in soft
tissue sites outside the skeleton. HO frequently complicates burns, arthroplasty, fractures …